Form 8-K - Current report:
SEC Accession No. 0001213900-23-003906
Filing Date
2023-01-20
Accepted
2023-01-20 08:00:36
Documents
12
Period of Report
2023-01-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea171925-8k_silopharma.htm   iXBRL 8-K 24565
  Complete submission text file 0001213900-23-003906.txt   197354

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE silo-20230115.xsd EX-101.SCH 3233
3 XBRL LABEL FILE silo-20230115_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE silo-20230115_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT ea171925-8k_silopharma_htm.xml XML 3603
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 23538936
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl